<--- Back to Details
First PageDocument Content
Health / Multi-drug-resistant tuberculosis / Pyrazinamide / Extensively drug-resistant tuberculosis / Ethambutol / Rifampicin / Vitamin D / Moxifloxacin / Tuberculosis treatment / Tuberculosis / Medicine / Microbiology
Date: 2009-05-29 08:02:34
Health
Multi-drug-resistant tuberculosis
Pyrazinamide
Extensively drug-resistant tuberculosis
Ethambutol
Rifampicin
Vitamin D
Moxifloxacin
Tuberculosis treatment
Tuberculosis
Medicine
Microbiology

Microsoft PowerPoint - Connell 2009

Add to Reading List

Source URL: www.tbinfo.ch

Download Document from Source Website

File Size: 1,58 MB

Share Document on Facebook

Similar Documents

VKM report 2014: 01 Evaluation of tolerable upper intake levels for vitamin D in children and adolescents Statement of the Norwegian Scientific Committee for Food Safety

DocID: 1vdlX - View Document

Supported Liquid Extraction of Vitamin D Metabolites: 25-hydroxy and 1α, 25-dihydroxy vitamin D2/D3 using PTAD Derivatization prior to LC-MS/MS Analysis Alan Edgington1, Lee Williams1, Rhys Jones1, Adam Senior1, Helen L

DocID: 1v16E - View Document

Comparison of 25-hydroxy Vitamin D Extraction using Supported Liquid Extraction and Phospholipid Depletion Plate Technology using Manual and Automated Sample Preparation prior to LC/MS Analysis Helen Lodder1, Kerry Chall

DocID: 1uLYU - View Document

Vitamin D Receptor (VDR) Gene Polymorphism: Implications on Non-Bone Diseases

DocID: 1uzsM - View Document

Why vitamin D is more effective in early-stage disease than late-stage disease PRESENTED BY PROF TREVOR MARSHALL Director, Autoimmunity Research Foundation Suntec Center, Singapore, China, Asian Congress on Autoimmunity,

DocID: 1u1AH - View Document